Data / Form D filings / LUX BIOSCIENCES INC
LUX BIOSCIENCES INC: Form D filings
LUX BIOSCIENCES INC, a biotechnology company in Jersey City, NJ, filed 7 Form D notices with the SEC between 2009 and 2012. The latest, on March 6, 2012, reports $16 million sold of a $17.1 million offering to 8 investors.
Find out what LUX BIOSCIENCES INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- HARBORSIDE FINANCIAL CENTER PLAZA 10, 14TH FLOOR, Jersey City, NJ, 07302
- Phone
- (201) 946-0551
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1366282
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 6, 2012 | New notice | $17,110,000 | $16,000,000 | $1,110,000 | 8 | Feb 23, 2012 | sec.gov |
| Dec 12, 2011 | New notice | $4,350,000 | $4,000,000 | $350,000 | 10 | Dec 5, 2011 | sec.gov |
| Jul 14, 2011 | New notice | $6,000,000 | $6,000,000 | $0 | 10 | Jun 30, 2011 | sec.gov |
| Mar 18, 2011 | New notice | $4,500,000 | $3,000,000 | $1,500,000 | 10 | Mar 3, 2011 | sec.gov |
| Dec 20, 2010 | New notice | $5,000,000 | $5,000,000 | $0 | 10 | Dec 3, 2010 | sec.gov |
| Oct 30, 2009 | New notice | $49,940,274 | $37,940,274 | $12,000,000 | 10 | Oct 15, 2009 | sec.gov |
| Jun 16, 2009 | New notice | $9,200,000 | $9,200,000 | $0 | 10 | Jun 3, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Clarke Schnell | Director | |
| A. Clarke Atwell | Executive Officer | |
| Eddy Anglade | Executive Officer | |
| Lutz Clarke Giebel | Director | |
| David Clarke Guyer | Director | |
| Paul Clarke Chaney | Director | |
| Axel Clarke Bolte | Director | |
| Thomas Clarke Dyrberg | Director | |
| Dean Clarke Mitchell | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Mar 5, 2012 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what LUX BIOSCIENCES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.